Cargando…

Applications of Proteomics in Ovarian Cancer: Dawn of a New Era

The ability to identify ovarian cancer (OC) at its earliest stages remains a challenge. The patients present an advanced stage at diagnosis. This heterogeneous disease has distinguishable etiology and molecular biology. Next-generation sequencing changed clinical diagnostic testing, allowing assessm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghose, Aruni, Gullapalli, Sri Vidya Niharika, Chohan, Naila, Bolina, Anita, Moschetta, Michele, Rassy, Elie, Boussios, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9150001/ https://www.ncbi.nlm.nih.gov/pubmed/35645374 http://dx.doi.org/10.3390/proteomes10020016

Ejemplares similares

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
por: Boussios, Stergios, et al.
Publicado: (2022)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
por: Boussios, Stergios, et al.
Publicado: (2019)

Hereditary Ovarian Cancer: Towards a Cost-Effective Prevention Strategy
por: Ghose, Aruni, et al.
Publicado: (2022)

Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
por: Ghose, Aruni, et al.
Publicado: (2021)

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
por: Boussios, Stergios, et al.
Publicado: (2020)

Wise Management of Ovarian Cancer: On the Cutting Edge
por: Boussios, Stergios, et al.
Publicado: (2020)

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
por: Vassiliou, Anna, et al.
Publicado: (2023)

From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary
por: Mathew, Beatrice Gadiel, et al.
Publicado: (2023)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022)

Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor
por: Boussios, Stergios, et al.
Publicado: (2015)

Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
por: Boussios, Stergios, et al.
Publicado: (2020)

Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
por: Uccello, Mario, et al.
Publicado: (2020)

Exosomes in the Diagnosis and Treatment of Renal Cell Cancer
por: Boussios, Stergios, et al.
Publicado: (2023)

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
por: Ioannidou, Evangelia, et al.
Publicado: (2021)

Proteomics in rheumatology: the dawn of a new era
por: Vanarsa, Kamala, et al.
Publicado: (2010)

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

Unraveling the Wide Spectrum of Melanoma Biomarkers
por: Revythis, Antonios, et al.
Publicado: (2021)

Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
por: Boussios, Stergios, et al.
Publicado: (2021)

BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
por: Shah, Sidrah, et al.
Publicado: (2021)

PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
por: Boussios, Stergios, et al.
Publicado: (2019)

Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered
por: Rassy, Elie, et al.
Publicado: (2020)

ERAS – The dawn of a new era!
por: Gopinath, Ramachandran, et al.
Publicado: (2019)

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer
por: Parent, Pauline, et al.
Publicado: (2023)

Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
por: Osseis, Michael, et al.
Publicado: (2022)

The dawn of a new era
Publicado: (2017)

The Dawn of the Post-Naturalness Era
por: Giudice, Gian Francesco
Publicado: (2019)

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review
por: Samartzis, Eleftherios P., et al.
Publicado: (2020)

The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?
por: Revythis, Antonios, et al.
Publicado: (2021)

COVID-19, Mucormycosis and Cancer: The Triple Threat—Hypothesis or Reality?
por: Mahajan, Ishika, et al.
Publicado: (2022)

Quarkonium physics at the dawn of the LHC era
Publicado: (2008)

New era dawns at home of the internet
Publicado: (2008)

Experimental Achievements at the Dawn of LHC Era
por: Šafarík,Karel
Publicado: (2012)

Ovarian cancer: state of the art and perspectives of clinical research
por: Boussios, Stergios, et al.
Publicado: (2020)

Efficacy and Safety of COVID-19 Vaccines—An Update
por: Sharma, Eshani, et al.
Publicado: (2022)

Impact of COVID-19 on cancer services and patients’ outcomes: a retrospective single-center study
por: Sain, Baijaeek, et al.
Publicado: (2023)

Heavy Ion Collisions at the dawn of the LHC era
por: Takahashi, J.
Publicado: (2011)

Pathogenesis of Dengue: Dawn of a New Era
por: Halstead, Scott B.
Publicado: (2015)

The dawn of a new era in treating T-PLL
por: Schrader, Alexandra, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uadjj6h3cvaf8rao4dsqif9cms